乙胺丁醇/异烟肼/利福平
| 组成 | |
|---|---|
| 乙胺丁醇 | 抗结核菌药物 |
| 异烟肼 | 抗结核菌药物 |
| 利福平 | 抗结核菌药物 |
| 临床资料 | |
| ATC码 | |
| 识别信息 | |
| CAS号 | 402507-77-1 |
| ChemSpider |
|
乙胺丁醇/异烟肼/利福平，是一种治疗结核病的固定剂量组合的口服复方药[1]。内含乙胺丁醇、异烟肼和利福平[1]。可以单独使用或与其他结核病诊治药物并用[1]。副作用与成份内的原药物副作用相同[1]。不适合用于儿童[1]。
参见
参考文献
- ^ 1.0 1.1 1.2 1.3 1.4 World Health Organization. WHO Model Formulary 2008. World Health Organization. 2009: 142. ISBN 9789241547659.
- ^ World Health Organization. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
延伸阅读
- World Health Organization. Rifampicin, Isoniazid, and Ethambutol hydrochloride (PDF) (报告). World Health Organization. February 2008. QAS/07.220/FINAL.
外部链接
- Ethambutol. Drug Information Portal. U.S. National Library of Medicine.
- Isoniazid. Drug Information Portal. U.S. National Library of Medicine.
- Rifampin. Drug Information Portal. U.S. National Library of Medicine.
